Publications of Lutz W. Kracht
All genres
Journal Article (57)
41.
Journal Article
10 (21), pp. 7163 - 7170 (2004)
Delineation of brain tumor extent with C-11 L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clinical Cancer Research 42.
Journal Article
10 (21), pp. 7163 - 7170 (2004)
Delineation of brain tumor extent with [C-11]L-methionine positron emission tomography: Local comparison with stereotactic histopathology. Clinical Cancer Research 43.
Journal Article
35 (8), pp. 1892 - 1898 (2004)
Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity. A comparative positron emission tomography/magnetic resonance Imaging study in early ischemic stroke. Stroke 44.
Journal Article
10 (6), pp. 420 - 425 (2004)
Organic and psychogenic factors leading to executive dysfunctions in a patient suffering from surgery of a colloid cyst of the Foramen of Monro. Neurocase 45.
Journal Article
34 (12), pp. 2908 - 2913 (2003)
Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke 46.
Journal Article
65 (3), pp. 291 - 305 (2003)
Imaging in gene therapy of patients with glioma. Journal of Neuro-Oncology 47.
Journal Article
54 (4), pp. 479 - 487 (2003)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Annals of Neurology 48.
Journal Article
34 (9), pp. 2152 - 2158 (2003)
Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 49.
Journal Article
13 (3), pp. 269 - 271 (2003)
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET. Journal of Neuroimaging 50.
Journal Article
30 (7), pp. 1051 - 1065 (2003)
PET-based molecular imaging in neuroscience. European Journal of Nuclear Medicine and Molecular Imaging 51.
Journal Article
30 (6), pp. 868 - 873 (2003)
Methyl- C-11 -L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. European Journal of Nuclear Medicine and Molecular Imaging 52.
Journal Article
44 (5), p. 167P - 167P (2003)
Identification of DNA and amino acid metabolism in human gliomas by PET. Journal of Nuclear Medicine 53.
Journal Article
44 (5, Suppl.), p. 164P - 164P (2003)
Multitracer PET and DW/PW-MRI in acute ischemic stroke: Assessment of neuronal damage and cerebral perfusion. Journal of Nuclear Medicine 54.
Journal Article
145 (Suppl.86), pp. 237 - 240 (2003)
Identification of malignant brain edema after hemispheric stroke by PET-imaging and microdialysis. Acta Neurochirurgica 55.
Journal Article
34 (1), p. 254 - 254 (2003)
Comparative imaging in acute ischemic stroke: Identification of penumbra and infarcted tissue by multitracer PET and PW/DW-MRI. Stroke 56.
Journal Article
13 (4), pp. 251 - 256 (2002)
Feasibility of source images of computed tomographic angiography to detect the extent of ischemia in hyperacute stroke. Cerebrovascular Diseases 57.
Journal Article
1 (3), pp. 187 - 204 (2002)
Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas. Technology in Cancer Research and Treatment Book Chapter (7)
58.
Book Chapter
Metabolic imaging. In: Neuro-Oncology: The essentials, 3. ed. Ed., pp. 66 - 76 (Eds. Bernstein, M.; Berger, M.S.). Thieme, Stuttgart (2015)
59.
Book Chapter
Brain tumors: Astrocytoma, oligodendroglioma, and glioblastoma. In: Clinical molecular anatomic imaging: PET/CT, PET/MR and SPECT CT, 3. ed. Ed., pp. 159 - 168 (Ed. Von Schulthess, G.K.). Lippincott Williams and Wilkins, Philadelphia, Penn. (2015)
60.
Book Chapter
PET in primary brain tumors. In: Functional Cerebral SPECT and PET Imaging, 4. ed., pp. 181 - 186 (Eds. van Heertum, R. L.; Tikofsky, R. S.; Ichise, M.). Wolters Kluwer [u.a.], Philadelphia [u.a.] (2009)